Insulin Resistance is a disorder that has recently affected a growing number of individuals. The frequency of Insulin Resistance diagnoses is increasing with the deterioration of the affected individuals' quality of life. It is presumed that improper diet, excessive stress, insufficient physical activity, and abdominal fat are the primary factors contributing to the development of this disorder. Although Insulin Resistance is not a separate disease, it should not be underestimated, as it provides a basis for the development of serious health issues.
Cellular insulin response dysfunction: pathophysiological mechanisms, etiologies, and metabolic sequelae
Insulin, a peptide hormone synthesized by pancreatic β-cells within the islets of Langerhans, serves as the principal regulator of carbohydrate metabolism by facilitating glucose uptake into target cells, where it functions as the primary energy substrate. Under physiological conditions, elevated blood glucose levels trigger proportional insulin secretion, thereby maintaining glycemic homeostasis. However, chronic hyperinsulinemia may induce desensitization of insulin receptors, impairing glucose uptake by peripheral tissues. The compensatory increase in insulin production by the pancreas (reactive hyperinsulinism) accelerates β-cell degeneration while exacerbating tissue resistance to the hormone’s effects. This condition, termed **insulin resistance**, is characterized by disrupted glucose homeostasis alongside normo- or hyperglycemia, stemming from reduced tissue sensitivity to insulin. Three core pathophysiological mechanisms are distinguished: **prereceptor** (e.g., mutated insulin syndrome with aberrant molecular structure), **receptor** (genetic mutations affecting insulin receptor encoding), and **postreceptor** (dysfunction of glucose transporters or signaling pathway disruptions). The etiology of insulin resistance is multifactorial, encompassing genetic predispositions, environmental factors (highly processed diets, physical inactivity), abdominal obesity, chronic stress, gut dysbiosis, and exposure to diabetogenic agents. This disorder constitutes a major risk factor for metabolic complications, including type 2 diabetes, metabolic syndrome, non-alcoholic fatty liver disease, and insulin-dependent malignancies. Clinical manifestations include postprandial somnolence, compulsive carbohydrate cravings, resistance to weight loss, cognitive impairment ('brain fog'), and chronic fatigue, reflecting profound metabolic and neuroendocrine dysregulation.
You have started reading a PRO article
You can preview the first chapter. To read the complete article and unlock all content, upgrade to a PRO account.